Kymera Therapeutics to Participate in Upcoming December Investor Conferences
Provided By GlobeNewswire
Last update: Nov 24, 2025
WATERTOWN, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats at the following upcoming investor events:
Read more at globenewswire.com
